3.229.117.123
dgid:
enl:
npi:0

Cardiovascular (38)

Evinacumab Cuts Cholesterol Levels by Half in Patients with HoFH

The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled trial of the drug, which is being presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of...

Read More